Authors:
Isomaa, B
Henricsson, M
Almgren, P
Tuomi, T
Taskinen, MR
Groop, L
Citation: B. Isomaa et al., The metabolic syndrome influences the risk of chronic complications in patients with Type II diabetes, DIABETOLOG, 44(9), 2001, pp. 1148-1154
Authors:
Henricsson, M
Sellman, A
Tyrberg, M
Groop, L
Citation: M. Henricsson et al., Progression to proliferative retinopathy and macular oedema requiring treatment. Assessment of the alternative classification of the Wisconsin Study, ACT OPHTH S, 77(2), 1999, pp. 218-223
Authors:
Henricsson, M
Sellman, A
Tyrberg, M
Groop, L
Citation: M. Henricsson et al., The alternative classification of the Wisconsin study - its ability to predict progression to retinopathy requiring treatment, ACT OPHTH S, 77(1), 1999, pp. 117-117
Authors:
Isomaa, B
Almgren, P
Henricsson, M
Taskinen, MR
Tuomi, T
Groop, L
Sarelin, L
Citation: B. Isomaa et al., Chronic complications in patients with slowly progressing autoimmune type 1 diabetes (LADA), DIABET CARE, 22(8), 1999, pp. 1347-1353
Authors:
Henricsson, M
Berntorp, K
Berntorp, E
Fernlund, P
Sundkvist, G
Citation: M. Henricsson et al., Progression of retinopathy after improved metabolic control in type 2 diabetic patients - Relation to IGF-1 and hemostatic variables, DIABET CARE, 22(12), 1999, pp. 1944-1949
Authors:
Szelag, B
Wroblewski, M
Castenfors, J
Henricsson, M
Berntorp, K
Fernlund, P
Sundkvist, G
Citation: B. Szelag et al., Obesity, microalbuminuria, hyperinsulinemia, and increased plasminogen activator inhibitor 1 activity associated with parasympathetic neuropathy in type 2 diabetes, DIABET CARE, 22(11), 1999, pp. 1907-1908